During the past decade, Onkodok GmbH conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkodok GmbH" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Onkodok GmbH" are "Chemotherapy-induced Peripheral Neuropathy" (1 trials), "Colorectal Cancer" (1 trials), "Malignant Haematological Tumour" (1 trials), "NSCLC, Stage III" (1 trials) and "Primary or Secondary Prophylactic Treatment" (1 trials). Many other conditions were trialed in "Onkodok GmbH" in a lesser frequency.

Most popular intervention types in "Onkodok GmbH" are "Drug" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Calmangafodipir (2 µmol/kg)" (1 trials), "Calmangafodipir (5 µmol/kg)" (1 trials), "Cyclophosphamide" (1 trials) and "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Onkodok GmbH" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Onkodok GmbH". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Onkodok GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Onkodok GmbH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".